Skip to main content

Table 3 Association of UA*, UA/Cr ratio* with COVID-19 and gender

From: Association of serum uric acid levels with COVID-19 severity

  Model 1 Model 2 Model 3
β (95% CI) β (95% CI) β (95% CI)
UA# COVID-19 −0.25 (− 0. 20, − 0.10) −0.21 (− 0.20, − 0.06) −0.15 (− 0.17, − 0.01)
Male 0.50 (0.22, 0.31) 0.53 (0.22, 0.33) 0.47 (0.19, 0.30)
COVID-19*Male −0.06 (− 0.15, 0.06) −0.001 (− 0.10, 0.10)
AIC −79.27 −78.03 − 111.46
BIC −63.68 −58.54 − 72.49
UA/Cr ratio# COVID-19 −0.21 (− 0.16, − 0.06) −0.13 (− 0.13, 0.01) −0.06 (− 0.11, 0.05)
Male −0.12 (− 0.10, − 0.01) −0.07 (− 0.09, 0.02) −0.08 (− 0.09, − 0.02)
COVID-19*Male −0.13 (− 0.20, − 0.01) −0.11 (− 0.18, 0.02)
AIC −68.02 −69.28 −83.80
BIC − 52.43 −49.80 −48.72
  1. Note: Linear regression analysis was used to assess association of UA*, UA/Cr ratio* with COVID-19 and gender
  2. Abbreviations: AIC Akaike information criterion, BIC Bayesian Information Criterions
  3. Model 1: Including COVID-19 and gender
  4. Model 2: Including Model 1 and COVID-19*gender
  5. Model 3 of UA#: Including Model 2 and LEU#†, LYM%, eGFR#†, ALB/GLB, FPG
  6. Model 3 of UA/Cr ratio#: Including Model 2 and LEU#†, LYM%, ALB/GLB, FPG
  7. The P-values are for the beta coefficient
  8. a#: The data were transformed into Ln (a)
  9. P <0.05